Related Experiment Video
Updated: Mar 24, 2026

08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
9.6K
Elucidating genes sufficient for viral entry into cells through sequential genome-wide CRISPR activation screens
Timothy Chai1, Alicia Wong1, Qingqing Yin1
1Institute for Stem Cell Biology & Regenerative Medicine, Department of Developmental Biology, Stanford University, Stanford, CA, USA.
Biorxiv : the Preprint Server for Biology
|March 23, 2026
Summary
Scientists developed a new CRISPR activation screening method to find genes that enable virus entry into cells. This approach overcomes limitations of previous methods and works for viruses like Ebola and rabies.
Area of Science:
- Virology
- Genetics
- Molecular Biology
Background:
- Discovering cellular genes crucial for virus entry is a key challenge in virology.
- Genome-wide loss-of-function screens identify necessary genes but are hindered by genetic redundancy.
Purpose of the Study:
- To develop and validate a genome-wide CRISPR activation screening strategy.
- To identify single genes sufficient for viral entry into normally uninfectable cells.
Main Methods:
- Utilized a genome-wide CRISPR activation screen.
- Employed sequential rounds of viral infection to enhance screening sensitivity.
- Applied the strategy to identify entry factors for Ebola and rabies viruses.
Main Results:
- The CRISPR activation screen successfully identified genes sufficient for viral entry.
- Sequential infection rounds significantly improved screening sensitivity.
- The method proved generalizable to distinct viruses, including Ebola and rabies.
Conclusions:
- CRISPR activation screening is a powerful tool for discovering viral entry factors.
- This strategy overcomes genetic redundancy issues inherent in loss-of-function screens.
- The approach has broad applicability for accelerating the discovery of host factors mediating viral entry.
Related Concept Videos
Genetic Screens
5.9K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.9K
CRISPR
58.9K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.9K
CRISPR/Cas9 Genome Editing
2.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.5K
CRISPR and crRNAs
19.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.5K

